DENVER, CO – June 19, 2025 – Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal moment ...
Ibogaine is the psychedelic compound derived from the iboga shrub, which is native to central Africa. Although people in other countries have been …
A new clinical program will use ibogaine, a naturally occurring psychedelic, to treat neurodegenerative conditions including Parkinson’s disease.
Ambio Life Sciences, which hosts other ibogaine programming and participates in scientific research about the drug, soft-launched the program in February. It is the first of its kind in the world, according to the company. People with Parkinson’s,
… ibogaine molecule, molecular structures, psychoactive substance, 3d model, Structural Chemical Formula and Atoms with Color Coding. Facebook …
Abbott signed a bill that will provide funding for research into Ibogaine, a plant-based hallucinogenic medicine.